Hjem › Galleveiskreft (kolangiokarcinom)
Kliniske studier for Galleveiskreft (kolangiokarcinom) rekrutterer i USA
56 studier for Galleveiskreft (kolangiokarcinom) rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- Houston, TX13 studier
- New York City, NY11 studier
- Boston, MA8 studier
- Rochester, MN7 studier
- Arlington, VA7 studier
- Los Angeles, CA7 studier
- Chicago, IL7 studier
- Columbus, OH6 studier
- Cleveland, OH6 studier
- Edison, NJ5 studier
- Queens, NY5 studier
- Grand Rapids, MI5 studier
- Nashville, TN5 studier
- San Antonio, TX5 studier
- Philadelphia, PA5 studier
- Tampa, FL5 studier
- Mountain View, CA5 studier
- Washington, DC5 studier
- Baldwin Park, CA5 studier
- Baltimore, MD5 studier
- Dallas, TX5 studier
- Miami, FL5 studier
- Orange, CA4 studier
- St. Louis, MO4 studier
- Durham, NC4 studier
- Seattle, WA4 studier
- Detroit, MI4 studier
- New Haven, CT4 studier
- Atlanta, GA3 studier
- West Valley City, UT3 studier
- Jacksonville, FL3 studier
- Salt Lake City, UT3 studier
- Buffalo, NY3 studier
- Birmingham, AL3 studier
- San Francisco, CA3 studier
- Louisville, KY3 studier
- Santa Monica, CA3 studier
Etter delstat
- Alabama3 studier
- Arizona3 studier
- California20 studier
- Colorado3 studier
- Connecticut6 studier
- Florida13 studier
- Georgia3 studier
- Illinois8 studier
- Kentucky4 studier
- Maryland9 studier
- Massachusetts10 studier
- Michigan8 studier
- Minnesota10 studier
- Missouri5 studier
- New Jersey8 studier
- New York15 studier
- North Carolina6 studier
- Ohio10 studier
- Pennsylvania5 studier
- Tennessee5 studier
- Texas15 studier
- Utah6 studier
- Virginia10 studier
- Washington4 studier
- Wisconsin4 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06728410Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT03942328Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
RekruttererObservasjonsstudie
Alder 2 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT01915225A Study of PHST001 in Advanced Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06840886A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06270706Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04645160PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
RekruttererFase 2
Alder 18 til 120 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05286814A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07265674[18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07673341Pemigatinib + Afatinib in Advanced Refractory Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06302621Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
RekruttererFase 2
Alder 19 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07146646A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07213791A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07488676Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06282575Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07780838Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT05732831Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT07282912Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 31. aug. 2026 · NCT05497531AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07619313Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04891289HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT06899152Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT07486713TCR1188-ABC Cells in KRAS-mutated Cancers
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 6. aug. 2026 · NCT07594067Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 3. aug. 2026 · NCT05285358D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. jul. 2026 · NCT06622057Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.